TGA to commence labelling, packaging regulatory review

The Therapeutic Goods Administration (TGA) is set to commence a review of the labelling and packaging regulatory framework for prescription medicines, over the counter medicines and complementary medicines. The TGA Transparency Review Report comprises recommendations relating to the labelling of medicines.The TGA will be considering the submissions to the review and the relevant sections of the report.The Australian Government is yet to accept the recommendations.